ED
KLDO

Exane Derivatives’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Exane Derivatives’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,333
Closed -$157K – 1074
2021
Q2 		$157K Hold
21,333
– – 0.04% 450
2021
Q1 		$173K Buy
+21,333
New +$173K 0.05% 317